Impact Factor
3.25
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.53
599 total citations
h5-index
21
h5 depth signal
Cited share
70.0%
189 of 270
Total citations
599
Citation footprint
Metric signal
2.19
External metric anchor
Self-citation
12.2%
73 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Turkey
759
China
375
United States
54
United Kingdom
43
South Korea
43
Citing Fields of Research
Digestive Disorders
734
Liver Diseases
323
Hepatitis
289
Inflammatory Bowel Diseases & Infections
174
Liver & Colon Cancer
172
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,712
Articles tracked across the journal lifetime
Indexed publication set
270
189 cited publications
Last 12 months
155
12.9 publications/month
Open access share
97.4%
151 OA publications in the last year
Leading citing country
Turkey
759 citing publications
Leading citing field
Digestive Disorders
734 citing publications
Latest tracked publication
12 October 2026
10 recent records available
Coverage & Indexing History
v14n1, Mar. 2003-
v14n1, Mar. 2003-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Digestive Disorders
Hepatitis
Liver Diseases
Noncoding RNA
Inflammatory Bowel Diseases & Infections
Issuing & Sponsoring Bodies
Contributor
Türk Gastroenteroloji Derneği
Broad Categories
Gastroenterology
Digestive Disorders
Liver & Colon Cancer
Hepatitis
Inflammatory Bowel Diseases & Infections
Liver Diseases
MeSH Descriptors
Gastrointestinal Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.5152/tjg.2026.26369
Open DOI
Tacrolimus-Associated Focal Pancreatitis Mimicking a Pancreatic Mass in a Renal Transplant Recipient
Cite this article as: Günegül Y, Şenocak İE, Eminler AT, Dheir H. Tacrolimus-associated focal pancreatitis mimicking a pancreatic mass in a renal transplant recipient. Turk J Gastroenterol. Published online October 12, 2026. doi: 10.51...
02
DOI 10.5152/tjg.2026.26411
Open DOI
Comment on “Gastrointestinal Bleeding in Small Intestinal Stromal Tumors: A Clinicopathological and Survival Analysis”
Cite this article as: İzol H, Ayhan R. Comment on “gastrointestinal bleeding in small intestinal stromal tumors: A clinicopathological and survival analysis.” Turk J Gastroenterol. Published online October 8, 2026. doi: 10.5152/tjg.2026....
03
DOI 10.5152/tjg.2026.26586
Open DOI
Intestinal Behçet’s Disease in the Era of Biologics: Current Evidence and Future Perspectives
Intestinal Behçet’s disease (BD) is a rare but potentially life-threatening manifestation of Behçet’s syndrome characterized by recurrent gastrointestinal symptoms and typical intestinal ulceration on endoscopic and radiological examinat...
04
DOI 10.5152/tjg.2026.26405
Open DOI
Validation and Reliability of the Turkish Version of the Inflammatory Bowel Disease–Disk in Patients with Inflammatory Bowel Disease
Background/Aims: The inflammatory bowel disease–disk (IBD-Disk) is a visual patient reported outcome measure designed to assess disease-related burden in patients with IBD. This study aimed to translate and culturally adapt the IBD-Disk ...
05
DOI 10.5152/tjg.2026.26128
Open DOI
Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter pylori Treatment: A Multicenter Real-World Observational Study
Background/Aims: Minocycline is a semisynthetic tetracycline with potent antimicrobial activity against Helicobacter pylori (H. pylori) and favorable pharmacokinetic properties. Although minocycline-based bismuth quadruple therapy (BQT) ...
06
DOI 10.5152/tjg.2026.26534
Open DOI
Pitfalls in the Diagnosis and Classification of Crohn’s Disease: Misdiagnosis, Overdiagnosis, and Misclassification
Crohn’s disease (CD) remains challenging to diagnose and classify accurately despite advances in endoscopy, cross-sectional imaging, intestinal ultrasound, and inflammatory biomarkers. Earlier diagnosis and treat-to-target strategies hav...
07
DOI 10.5152/tjg.2026.26373
Open DOI
Serum X-C Motif Chemokine Ligand 1 Is Associated with Endoscopic Activity in Crohn’s Disease: A Clinical Biomarker Study
Background/Aims: Monitoring endoscopic inflammation in Crohn’s disease (CD) is difficult. This study examined whether X-C motif chemokine ligand 1 (XCL1) is associated with endoscopic activity, as defined by the Simple Endoscopic Score f...
08
DOI 10.5152/tjg.2026.264112
Open DOI
Author’s Response for Comment on “Gastrointestinal Bleeding in Small Intestinal Stromal Tumors: A Clinicopathological and Survival Analysis”
Cite this article as: Lai Y. Author’s Response for Comment on “Gastrointestinal Bleeding in Small Intestinal Stromal Tumors: A Clinicopathological and Survival Analysis.” Turk J Gastroenterol. Published online October 5, 2026. doi: 10.51...
09
DOI 10.5152/tjg.2026.26102
Open DOI
Comparative Effectiveness of Vedolizumab and Ustekinumab in Biologic-Experienced Ulcerative Colitis: A Real-World Multicenter Study from the Güntürk Group
Background/Aims: The study aimed to compare the effectiveness and safety of vedolizumab (VDZ) and ustekinumab (UST) in patients with ulcerative colitis (UC) previously exposed to biologic therapy and to determine whether prior biologic e...
10
DOI 10.5152/tjg.2026.26525
Open DOI
Long-Term Serum Amyloid A Profile in Clinically Stable Pediatric Liver Transplant Recipients
Background/Aims: Serum amyloid A (SAA) is an acute-phase protein whose sustained elevation is required for AA amyloid fibril formation. Although AA amyloidosis is a rare complication of solid organ transplantation, the long term SAA prof...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 28 (2017).
Also issued online.
In English and Turkish; English only, 2014- .